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Abstract 
Drosoplzila nemo encodes a serine threonine MAP kinase that is involved in 
patterning and cell fate determination. nemo participates in crosstalk with several 
pathways; with studies linking the vertebrate homologue, nlk to the TGFP pathway. 
TGFPs are structurally related extracellular polypeptides including the Bone 
Morphogenetic Proteins (BMPs) that are potent regulators of development. 
In Drosophila the BMP molecules Decapentaplegic (Dpp) and Glass bottom boat 
(Gbb) promote vein formation while Nemo promotes intervein fates. Genetic studies 
revealed that Nemo counteracts the effects of components of the BMP pathway; and 
nemo mutant pupal wings show high levels of BMP signalling activity in ectopic veins, 
supporting an inhibitory role for Nemo on BMP activity. 
These studies show that nemo may act as a negative regulator of TGFP signalling; 
and supports the emerging roles of nemo as an important regulator of signalling in 
different pathways. 
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Chapter One: Introduction 
Multicellular organisms develop from a single cell that differentiates into distinct 
and specialized tissues. This process requires well organized and coordinated signals 
between individual cells; a function that is achieved through effective communication 
between cells. This ensures correct patterning and organization of the embryo into the 
distinct structures that make up the adult body. Cell-cell communication is also vital in 
regulated growth, homeostasis and defensive mechanisms in the adult body. Genetic 
pathways play fundamental roles in development; and interact with each other to ensure 
that cells receive the appropriate signals at the right time and in the required amounts. 
The importance of these pathways and their regulation in development is manifest in the 
several developmental conditions associated with loss or deregulation of their 
components. This has made the challenge to understand and characterize genetic 
pathways and their modes of action very crucial in addressing several developmental 
problems. 
The transforming growth factor beta family 
Members of the transforming growth factor P (TGFP) family of growth factors 
have been shown to play important roles in various biological processes. The family 
consists of structurally related soluble extracellular polypeptides which have diverse roles 
in growth and development, homeostasis, and repair of tissues in both vertebrates and 
invertebrates (Massague, 1998; Rafiery and Sutherland, 1999). The importance of this 
pathway is demonstrated in the multitude of human disorders that are associated with its 
dysfunction. Among the effects of TGFQ on target cells is cell cycle arrest at the G1 
phase and the loss of this growth inhibitory effect due to defects in TGFP signalling is 
one of the possible causes of cancer (Massague, 1998). Abnormal TGFQ activity is also 
implicated in a number of inflammatory disorders. Excessive TGFQ signalling underlies 
various disorders of the kidney, lung, liver, and other organs (reviewed in Massague, 
1998). 
The TGFQ family of growth factors are characterized by the presence of six 
conserved cysteine residues, and consists of three major subfamilies namely TGFPs, 
Activins and Bone Morphogenetic Proteins (BMPs). The TGFP subgroup is involved in 
early embryonic development and also has roles in late development and in adult tissues. 
It also functions as a growth inhibitor of most cell types including epithelial cells, 
endothelial cells, haematopoietic cells and lymphocytes (reviewed in Miyazono, 2000). 
Activins and BMPs perform vital roles in early embryogenesis and direct patterning of 
the early embryo. In addition BMPs are further involved in the morphogenesis of most 
tissues. Signalling by this family of proteins controls the development and homeostasis of 
almost all cell types, and constitutes a bulk of intercellular signals between cells. The 
importance of the TGFP family has led to its characterization in most organisms and it is 
found to be well conserved in both vertebrates and invertebrates. Table 1 lists some 
components of the TGFP pathway in various organisms. 
A family of transmembrane protein serinelthreonine kinases (Types I and I1 
receptors) transduce the TGFP signal from the extracellular matrix to the cytoplasm. The 
receptors activate the Smad family of cytoplasmic proteins which move into the nucleus 
to regulate the transcription of target genes. There are three kinds of Smads; receptor 
regulated Smad (R-Smad) that binds to the receptors and mediate signalling; common 
mediator Smad (Co-Smad) which takes part in TGFP signalling by associating with the 
R-Smads; and inhibitory Smad (I-Smad) that antagonizes ligand-dependent signalling. 
In Drosophila, the BMP subclass of TGFP has been well characterized and 
includes Glass bottom boat (Gbb), Decapentaplegic (Dpp) and Screw (Scw) (Padgett et 
al., 1987; Wharton et al., 1991; Arora et al., 1994; Doctor et al., 1992; Khalsa et al., 
1998). Dpp has a variety of biological roles including dorsoventral patterning of the 
embryo, gut formation, as well as outgrowth and patterning of the eye and wing imaginal 
discs (Sekelsky et al., 1995). Gbb is also involved in larval cuticle patterning, midgut 
morphogenesis and wing vein patterning (Doctor et al., 1992; Khalsa et al., 1998; 
Wharton et al., 1999). Dpp and Gbb form heterodimers and act together to regulate 
development in certain contexts; but also have independent roles, in which case they 
signal as homodimers. Scw play roles in the patterning of the dorsal epidermis (Ray and 
Wharton, 2001). These ligands signal through a common Type I1 receptor called Punt 
(Put), but utilize different Type I receptors. Dpp and Gbb signals are mediated through 
Thickveins (Tkv) while Saxophone (Sax) is employed in Scw signalling (Nguyen et al., 
1998). Recently another Type I1 receptor, Wishful thinking (Wit) has been identified and 
was shown to mediate BMP signalling at neuromuscular junctions (Marques et al., 2002; 
2003). The R-Smad Mothers against Dpp (Mad) and the Co-Smad, Medea (Med) mediate 
signalling downstream of Tkv. Mad and Medea are homologues of vertebrate Smadl and 
Smad4 respectively. Among the target genes of Dpp signalling is the inhibitory Smad, 
Daughters against Dpp (Dad) which is related to vertebrate Smads 6 and 7 and is 
involved in a feedback loop to inhibit Dpp signalling (Tsuneizumi et al., 1997). 
The Types I and I1 receptors are glycoproteins that share conserved features, 
including an N-terminal extracellular region, a transmernbrane domain and a C-terminal 
kinase domain (Shi and Massague, 2003). The major difference between these receptors 
is the presence of a 30-amino acid region preceding the kinase domain in the Type I 
receptors. This region consists of a characteristic glycine-serine (TTSGSGSGLP) 
sequence and is therefore referred to as the GS domain, which contributes to the 
activation state of the receptors (reviewed in Massague, 1998; Zimmerman and Padgett, 
2000). The GS domain exists in a wedge-like conformation within the catalytic domain of 
the receptor, thus rendering it inactive in the absence of a ligand (Huse et al., 1999). The 
active TGFP ligands exist as dimers that are stabilized through hydrophobic interactions 
and disulphide bonds (Shi and Massague, 2003). In the absence of ligand, the receptors 
exist as homodimers at the cell surface but the ligand dimers generally recruit them into 
heterotetrameric complexes (thereby bringing these two receptors in close proximity with 
each other) (Fig. 1). The formation of these receptor complexes is crucial for signalling 
by the receptors (reviewed in Massague, 1998; Derynck and Zhang, 2003), as it allows 
easy access of the Type I receptor to the activated type I1 receptor. The ligands induce 
autophosphorylation of the Type I1 receptor on serine residues in its kinase domain. The 
activated Type I1 receptor then phosphorylates the Type I receptor on serine and 
threonine residues in its GS region, causing the GS region to be dislodged from the 
catalytic domain. It is important that the Type I receptor remains inactive and only 
induced through ligand activation of the Type I1 receptor. There is evidence from yeast 
and mammalian cells that indicate that certain proteins bind to the GS domain of the 
Type I receptor to prevent its phosphorylation in the absence of ligand (Huse et al., 
1999). 
Figure 1: The TGFB pathway 
ECM 
Abbreviations: ECM- Extracellular matrix, GS- GS domain; KD- Kinase domain I- Type I receptor; II- 
Type 11 receptor. The TGFB ligands bind to the receptors as homodimem, and induce receptor hetero- 
oligomerization and phosphorylation of the Type I receptor in the GS domain by the Type 11 receptor. 
SARA presents R-Smad to the activated Type I receptor, and R-Smad is phosphorylated. Phosphorylated 
R-Smad complexes with Co-Smad and moves into the nucleus to associate with co-activators or repressors 
to regulate transcription of target genes. I-Smads compete with R-Smads for biding to the receptor, and 
also block R-SmadICo-Smad oligomerization. Smurftargets R-SmadII-Smad for degradation. 
An essential component of the pathway is the Smad family of proteins that 
mediate signalling downstream of the Type I receptors in the cytoplasm. The Smads 
typically consist of conserved N-terminal Mad homology l(MH1) and a C-terminal Mad 
homology 2 (MH2) domains which are separated by a poorly conserved proline-rich 
linker region (Christian and Nakayama; 1999) (Fig. 2). Both MHI and MH2 domains are 
present in R-Smads and Co-Smads but the I-Smads lack an MHI domain. The MH2 
domain interacts with receptors as well as DNA binding proteins and transcription 
factors. This domain contains a number of serine residues (SSXS) located at its C 
terminal end, the distal two of which are necessary for activation by the receptors. The 
MHI domain is involved in DNA binding. In the inactivated state, the MHI and MH2 
domains interact and this interaction leads to inhibition of MH2 transcriptional and 
biological activity. The MH1 domain therefore inhibits MH2 activation in the absence of 
signalling; hence providing a level of regulation of signalling. The linker region is 
important in homo-oligomerization of the Smads, and also contains MAPK 
phosphorylation sites that provide a potential point of crosstalk with other pathways 
(reviewed in Massague, 1998). 
The R-Smad is recruited to the activated Type I receptor and is phosphorylated on 
the two distal C-terminal serines SXS. Once activated, R-Smad associates with the Co- 
Smad. This R-SmadICo-Smad complex then translocates to the nucleus to regulate the 
transcription of target genes. The pathway specific Smads (R-Smad and Co-Smad) exist 
as monomers but are induced to form homo-oligomers and hetero-oligomers in response 
to receptor activation (Kawabata et al., 1998). Smad oligomerization is mediated through 
the MH2 domain. The subcellular localization of Smads is controlled to regulate 
signalling. There is a nuclear localization signal (NLS) made up of a Lys-Lys-Leu-Lys 
sequence located at the N-terminal region of the Smads that ensure their nuclear import. 
On the other hand, a Leucine-rich nuclear export signal (NES) in the vertebrate Co-Smad, 
Smad4 keeps it in the cytoplasm in unstimulated cells (Watanabe et al., 2000). 
Figure 2: Schematic diagram showing the structure and domains of Smads 
Co-Smad 
Linker 
PY 
MHl and MH2 inhibit each other in the absence of ligand; activated receptor phosphorylates R-Smad on 
the C-terminal distal mine residues. MH1 domain is important for binding to DNA, and is missing in I- 
Smads which also have a longer linker region. Also shown are various motifs that play essential roles in 
Smad signalling and interaction. NLS in both R- and Co-Smads enhance their nuclear import, while NES 
induce export of Co-Smad fiom the nucleus. The PY motifs in the linker region of R-Smads and I-Smads 
are important for interacting with the WW motif of Smurf, and could be targeted by other proteins 
Ligand-induced complex formation between R- and Co-Smad is thought to be necessary 
to relieve their nuclear export (reviewed in Itoh et al., 2000). The mechanisms regulating 
Smad localization are not well understood; however emerging evidence indicate that 
cytoplasmic and nuclear retention factors may be involved. These factors are presumably 
selective in interacting with Smads, with cytoplasmic factors binding preferentially to 
monomeric Smads, while nuclear factors likely bind to complexed Smads (reviewed in 
ten Dijke and Hill, 2004). For example, the nuclear export protein, chromosome region 
maintenance 1 (CRM1) was shown to bind to the NES region of Smad4 (Pierreux et al., 
2000; Watanabe et al., 2000), while importin-a interacts with the NLS of the same Smad 
to induce its nuclear import (Pierreux et al., 2000; Watanabe et al., 2000; Xiao et al., 
2003). Interaction with the activated receptor is therefore critical in determining the 
localization of Smads, as it will presumably induce their release from cytoplasmic 
retention factors and promote their association with nuclear import factors. Hence in the 
absence of ligand, both R and Co-Smads remain chiefly in the cytoplasm, and move into 
the nucleus only after phosphorylation of the R-Smads by the activated receptor. 
Smads are shown to be presented to the receptor by an anchor protein, Smad 
anchor for receptor activation (SARA). SARA contains a central 
- 
Fab 1 p/Y_OTP/yacl p/EEAl (FYVE) domain, consisting of two zinc-finger motifs. FYVE 
- 
domains are present in several proteins that mediate endocytic vesicular traffic; and are 
known to bind phosphatidylinositol-3-phosphate to tether proteins at endosomal 
membranes (Wurmser et al., 1999). SARA resides at the cell membrane through the 
lipid-binding FYVE domain; and interacts with Smads through its Smad-binding domain. 
It also contains a C-terminal domain which binds the Type I receptor. In this way, SARA 
promotes effective recruitment of R-Smads to the receptor (Fig. 1). The R-Smad-SARA 
complex is disrupted upon phosphorylation of the R-Smads, thus allowing the Smads to 
move into the nucleus (Tsukazaki et al., 1998). 
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Control of gene expression by Smads 
Once in the nucleus the R-SmadICo-Smad complex interacts with co-activators or 
co-repressors that determine their transcriptional activity. This final step in TGFP 
signalling is important in determining which genes are turned on in response to different 
TGFB signals and in varying contexts. Irrespective of the TGFB ligand that activates 
them, R- and Co-Smads recognize and bind with low affinity to the sequence CAGAC 
(also referred to as Smad binding element (SBE)) on DNA (Shi et al., 1998) and thus 
require DNA-binding co-factors to allow efficient regulation of specific target genes 
(Massague and Chen, 2000). The cell-specific expression of these co-factors determines 
which cells express TGFS-responsive genes both spatially and temporally. As such, these 
co-factors are selective in the kinds of TGFB target genes they activate, through 
differential association with individual Smads, leading to pathway specific activation of 
various TGFP target genes (Table 2). For example, the winged-helixlforkhead family 
member forkhead gctivin ~ignal  iransducer- 1 (FAST- 1 ) interacts with Smad2 and Smad4 
to mediate the expression of the Mix.2 gene in Xenopus, in response to activin-like 
signals. FAST-I does not associate with other Smads and hence does not promote BMP 
signalling for example. On the other hand, the 30 zinc finger nuclear protein Qlf-IIEBF 
associated zinc factor (OAZ), associates with the Smadl -Smad4 complex in Xenopus to 
- 
promote the expression of BMP-induced Xvent2. OAZ is limited to the BMP pathway 
and mediates BMP target gene expression only. In Drosophila, the homeobox 
transcription factor tinman cooperates with Mad and Medea to regulate its own 
transcription in response to BMP signalling (Massague and Wotton 2000; Zimmerman 
and Padgett, 2000). 
Table 2: Various Smad transcriptional regulators and their effects on signalling 
Organism 
V) 
-
I Activin I Smad2,3,4 I FAST-1 I mix.2, nodal, I activation 
BMP 
TGFP 
TGFP 
TGFP 
TGFP 
Ligand type 
TGFP 
TGFP, BMP 
TGFP, 
Activin 
Smadl 
Smad2,3,4 
Smad2,3 
Smad2,3 
Smad2,3 
TGFP, 
Regulator 
MSG1 
CBPlp300 
c-Junlc-Fos 
Interacting 
Smad 
Smad4 
Smad1,2,3,4 
Smad3,4 
3- 
c 
% 
Hoxc-8 
SkilSnoN 
SIP1 
SNIP1 
TGIF 
Smad2,4 
Activin 
BMP 
Target gene 
? 
? 
c-fos 
Activin 
TGFP, 
Q 
m 
c7 .= 
Abbreviations: Act, Activin; FAST, forkhead activin signal transducer; MSG, melanocyte specific gene; 
sal, spalt; SIP, Smad interacting protein; SkiISnoN, Sloan-Kettering avian retrovirus/ski-related novel gene. 
Effect 
activation 
activation 
activation 
osteopontin 
? 
? 
? 
? 
FAST-2 
OAZ 
T L 
n 
Smads interact with the cyclic adenosine mono phosphate (CAMP) response 
binding (CREB) binding protein (CBPlp300) through the MH2 domain, and use them as 
transcriptional co-activators to induce target gene transcription (Janknecht and Wells, 
1998). Drosophila Mad is shown to interact with the CBPlp300 homologue Nejire (Nej) 
to activate transcription of Dpp target genes (reviewed in Torres-Vazquez, 2001). CBP 
and p300 have histone acetylase iransferase (HAT) activity which enables them to 
modify chromatin structure, and probably expose specific promoter sequences to DNA 
binding proteins such as the Smads (Massague and Wotton, 2000). The HAT activity of 
these co-activators on DNA enhances transcriptional activation. Conversely, histone 
d e a a l s e s  (HDACs) repress transcription by causing tighter nucleosomal packing of 
- 
repression 
repression 
repression 
repression 
repression 
Smad2 
BMP 
BMP 
lefty 
goosecoid 
Xvent-2 
BMP I MadlMedea I CREB? 
activation 
Mixer 
activation 
MadlMedea 
Mad? 
ubx I coactivator 
goosecoid 
Tinman 
Brinker 
activation 
-
tinman 
sal 
. -  ~~- 
~~activator 
remession 
DNA and impair the accessibility of promoter sequences to transcription factors. Some 
transcriptional co-repressors inhibit transcription by recruiting the HDACs. An example 
is the TGFP inhibitory factor (TGIF), a homeodomain protein that forms a complex with 
Smads and recruits HDACs to inhibit Smad transcriptional activity. The structurally 
related proto-oncogenes Ski and SnoN also repress Smad transcriptional activity by 
recruiting the HDACs. Another repressor, Smad nuclear interacting protein 1 (SNIP 1) is 
found to interact with Smad4 and CPBlp300 to suppress TGFP signalling (reviewed in 
Itoh et al., 2000). As a result of all these interactions Smad transcriptional activity in the 
nucleus is well regulated both temporally and spatially in response to specific TGFP 
signals. TGFP signalling usually leads to direct activation of target genes; however 
evidence suggests that signalling may also activate genes indirectly by de-repressing 
certain target genes from the effects of inhibitors. This view is supported by studies from 
dauer development in C. elegans. In response to unfavourable environmental conditions, 
C. elegans L3 larvae arrest as dauer, a state that allows them to survive and move away 
from suboptimal conditions. The Co-Smad-related protein, DAF-3 induces dauer 
formation even under ideal conditions. This activity of DAF-3 is inhibited by BMP 
signalling to prevent worms from undergoing dauer arrest under optimal conditions 
(reviewed in Patterson and Padgett, 2000). DAF-3 is similar to Co-Smads but appears to 
have distinct functions (Patterson and Padgett, 2000). DAF-3 is also shown to recognize 
and bind to the sequence, GTCTG in the myo-2 gene to repress its transcription. The 
myo-2 gene product is a component of the pharyngeal muscle in C. elegans (Thatcher et 
al., 1999). This inhibitory activity of DAF-3 is also repressed by TGFP signals (Thatcher 
et al., 1999). Another example is found in Drosophila, where the transcriptional 
repressor, Brinker inhibits the transcription of Dpp target genes. Dpp signalling leads to 
inhibition of Brinker activity, as a result de-repressing and allowing the transcription of 
these genes (Jazwinska et al., 1999). 
Regulators of TGFP signalling 
There are several mechanisms in place to ensure that cells do not receive 
excessive TGFP signals. A number of negative regulators (including I-Smads) exist to 
monitor TGFP signal levels in the cell. The I-Smads function mainly as negative 
feedback antagonists of TGFP signalling. These Smads lack the C-terminal 
phosphorylation sites (i.e. the SSXS motif, Fig. 2) and as such are able to bind to the 
receptor without being phosphorylated. It is proposed that these proteins inhibit signalling 
through competing with the R-Smads for binding to the Type-I receptor as well as 
competing with Co-Smads for association with activated R-Smads (Itoh et al., 2000). 
Smad6 and Smad7 are the inhibitory Smads in vertebrates and specifically repress BMP 
signalling; however Smad7 is able to antagonize other TGFP signals as well (Nakao et 
al., 1997). Smad7 is recruited to the Type I receptor by the serinelthreonine kinase 
receptor-associated protein (STRAP) to exert its effect on signalling (Datta and Moses, 
2000). In Drosophila, Dad, which is induced in response to Dpp signalling, functions in a 
negative feedback loop to inhibit Dpp. Similar to the scenario in vertebrates, Dad is 
proposed to interact with Mad to prevent it fiom being activated by the receptor; and also 
competes with Mad for binding to the type I receptor, Tkv (Tsuneizumi et al., 1997). The 
antagonistic function of I-Smads in the feedback circuit ensures that TGFP signalling is 
well modulated. 
Emerging studies also ascribe positive roles to I-Smads in TGFP signalling. 
Smad6 and Smad7 were shown to mediate TGFP-induced adipocyte differentiation, while 
Smad7 upregulation by TGFP is found to be critical in apoptosis of prostate carcinoma 
cells (Choy et al., 2000; Landstrom et al., 2000). The mechanism of this positive 
modulation of signalling by I-Smads is however not clear. I-Smads are predominantly 
nuclear and are exported to the cytoplasm in response to signalling (reviewed in Itoh et 
al., 2000) probably to effectively modulate signalling. Given the conserved nature of the 
Smads in various organisms, it is surprising that no I-Smad has yet been discovered in C. 
elegans (Patterson and Padgett, 2000). 
There are additional factors that control TGFP signalling at different levels of the 
pathway. A number of studies show that certain proteins regulate the accessibility of the 
ligands to the receptors. Ligands of the TGFP subfamily are expressed as inactive 
precursor molecules that are cleaved in the secretory pathway into an amino terminal 
propeptide and a carboxy-terminal fragment which is the mature growth factor. A number 
of proteins including thrombospondin-1 (TSP-I), act on the inactive molecules to make 
them functional (Crawford et al., 1998). Unlike TGFP, Activins and BMPs are 
synthesized as active molecules but their activity in the extracellular matrix is regulated 
by a number of antagonists (Miyazono et al., 2000) that bind and prevent their access to 
the receptors. Both Activins and BMPs are inhibited by the secreted glycoprotein, 
Follistatin. Activin induces the release of follicle stimulating hormone (FSH) from the 
pituitary, an effect inhibited by Follistatin which prevents binding of Activin to the 
receptors. In a similar way, Follistatin counteracts the inhibitory action of BMPs on 
Xenopus neural fate (Hemmati-Brivanlou et al., 1994). Other BMP antagonists are the 
secreted proteins Chordin and Noggin, both of which are expressed in the Spemann's 
organizer (a signalling centre located at the dorsal lip of the amphibian gastrula 
blastopore) of the amphibian embryo and inhibit BMP-induced ventral mesoderm 
(Zimmermann et al., 1996; Piccolo et al., 1996). Both Noggin and Chordin contain 
cysteine-rich (CR) repeats and prevent BMPs from interacting with the receptors. Short 
gastrulation (Sog) is the Chordin homologue in Drosophila which antagonizes BMP 
ligands (Holley et al., 1996). Sog is found to inhibit the activity of Screw, and genetic 
data also show that Sog has inhibitory effects on signalling mediated by Dpp (Yu et al., 
1996). These negative regulators ensure that signalling is activated in the right cells; and 
also help establish concentration gradients of the ligands across the developing embryo 
(Marques et al., 1997). The latter role is very important due to the morphogenetic nature 
of the ligands and the varying concentration-dependent roles they perform in directing the 
specification of different parts of the embryo. 
Another important and complex aspect of TGFP signalling is the presence of 
agonists that inhibit the activities of the extracellular antagonists enumerated above. This 
action is mediated by secreted metalloproteases which cleave the BMP antagonists to 
release free and active ligands. These include Drosophila Tolloid and Tolloid-related 1 
(Tlr-1) and their orthologues in Xenopus (Xolloid) and human (BMPI and hTldl). 
Xolloid acts on Chordin while Tolloid interacts with Sog in Xenopus and Drosophila 
respectively to relieve the repression of the respective BMP ligands (reviewed in 
Massague and Chen, 2000). Ashe and Levine (1999) observed that the interaction 
between Sog and Tolloid is needed to establish a gradient of Dpp activity which 
subdivides the dorsal ectoderm of the Drosophila embryo into amnioserosa and dorsal 
epidermis. Conley and colleagues (Conley et al., 2000) recently identified another 
possible Drosophila BMP agonist, Crossveinless-2, which presumably inhibits the action 
of Sog during crossvein specification. The Twisted gastrulation (Tsg) protein performs a 
complex role to act as an agonist and antagonist in different contexts. In Xenopus, Tsg 
binds to Chordin-BMP complex to modulate signalling, and help release the active BMP 
ligand (Oelgelschlager et al., 2000; 2003). Recent studies however suggest inhibitory 
roles for Tsg in BMP signalling; and implicate it to enhance the activity of both Chordin 
and Sog (Ross et al., 2001; Chang et al., 2001). The exact role Tsg is playing in BMP 
signalling is open to debate. 
Apart from ligand function, other proteins target the receptors to regulate 
signalling. Among these is the BMP and activin membrane-bound inhibitor (BAMBI), a 
transmembrane protein which shares sequence similarity with type I receptors in the 
extracellular domain (Onichtchouk et al., 1999). BAMBI forms heterodimers with Type I 
receptors and interferes with their activation. This protein is reported to strongly inhibit 
both BMP and activin signalling in Xenopus; and is also shown to act in a negative 
feedback loop to suppress BMP signalling during Xenopus embryogenesis (Onichtchouk 
et al., 1999). 
Signalling is also regulated by other proteins that control R-Smad availability. 
Smad ubiquitination regulatory factors (Smurfs) are a group of ubiquitination ligases that 
bind specifically to R-Smads and target them for proteosome-mediated ubiquitination and 
subsequent degradation (Ebisawa et al., 2001; Tajima et al., 2003). Smurfl is an E3 
ubiquitin ligase which contains the homologous to E6AP GOOH-terminus (HECT) and 
WW protein-protein interacting domains; the latter of which is involved in interacting 
with the PY motif of a proline-rich sequence present in the linker region of Smads 
(Massague and Chen, 2000). In Xenopus, Smurfl binds Smadl and induces its 
degradation; and ectopic expression of Smurfl inhibits Smadl-induced ventralization in 
embryos (Zhu et al., 1999). Smurfl and Drosophila Smurf (DSmurf) were also shown to 
recruit Smad7 and Dad respectively to the Type I receptor to enhance their inhibitory 
activity (Podos et al., 2001; Suzuki et al., 2002). 
Recent evidence also implicates microtubules as regulators of TGFP signalling in 
the cytoplasm. Dong et a1 (2000) showed that Smads are bound to microtubules (through 
P-tubulin); and probably become dissociated only after their phosphorylation by 
receptors. This interaction is likely to tether Smads in the cytoplasm to prevent their 
nuclear import and subsequent leaky activation of target genes in the absence of signal. 
Crosstalk between TGF$ and other signalling pathways 
In addition to the numerous factors that tightly control TGFP signalling at various 
levels, the pathway is M h e r  regulated through its integration with other signalling 
networks. Smad proteins provide several points of integration and interaction between 
signals arising from the TGFP family and other pathways. The mitogen activated protein 
kinases (MAPKs) p38 and Jun-N terminal kinase (JNK) enhance TGFP signalling. On the 
other hand, Smad7 is activated by signals from a number of sources including tumor 
necrosis factor alpha (TNFa) through NF-K B; and Interferon gamma (IFN y) through the 
Janus kinaseslsignal transducers and activators of transcription (JAWSTAT) pathway. In 
addition, activated Ras under the influence of the Epidermal Growth Factor (EGF) 
activates the extracellular signal regulated kinases (Erk) to block the R-Smad ICo-Smad 
complex from translocating into the nucleus (reviewed in Itoh et al., 2000). 
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Role of Nemo-like kinases in TGFP signalling 
A potential candidate that may be involved in regulating TGFP signalling is the 
Nemo-like kinase (Nlk); a mitogen activated protein kinase (MAPK) with important roles 
in development. Perhaps the strongest link between TGFP signalling and Nlks is through 
the TGFP activated kinasel (Takl). Takl is a MAPK kinase kinase (MAPKKK) which is 
activated in response to TGFP signalling (Yarnaguchi et al., 1995). The MAPK pathway 
mediates signalling downstream of various receptors to produce numerous cellular 
responses. This pathway is made up of three protein kinases, MAPKKK, MAPKK, and 
MAPK. MAPKKK phosphorylates and activates MAPKK, which in turn phosphorylates 
MAPK (Nishida and Gotoh, 1993). Takl activates a number of MAP kinases in culture, 
including JNK, p38 and Nlk (Moriguchi et al., 1996; Shirakabe et al., 1997; Wang et al., 
1997; Ishitani et al., 1999). Studies demonstrate that Tak activates Nlk homologues in 
response to TGFP signalling in mice and worms (Ishitani et al., 1999; Meneghini et al., 
1999; Shin et al., 1999). These findings implicate Nlks as potential modulators of TGFP 
signalling. Other targets of Takl including JNK and p38 also regulate TGFP signalling 
(Derynck and Zhang, 2003) although it is not known if they do so in response to Takl. 
Developmental roles of nlks 
Nemo-like kinases are proline-directed serine threonine protein kinases that play 
various roles in cell fate determination and pattern formation. The genes encoding these 
proteins are well conserved evolutionarily, with homologues in Drosophila (nemo), 
Caenorhabditis elegans (lit-]) and vertebrates (nemo-like kinases). Nlk and its 
homologues regulate various signalling pathways, including Wnt in C. elegans, Xenopus 
laevis and Drosophila (Meneghini et al., 1999, Rocheleau et al., 1999, Ishitani et al., 
1999, Verheyen et al., 2001; Zeng and Verheyen, 2004). Nemo (nrno) was first identified 
in Drosophila as an important component of eye formation. The Drosophila compound 
eye consists of roughly 800 eye units, termed ommatidia. Each of these can be visualized 
as a secreted hexagonal lens in the adult fly eye. Inside the ommatidium are 20 cells 
consisting of 8 photoreceptors and 12 accessory and pigment cells. The photoreceptor 
cells within the eye undergo a precise series of rotations during their development. nrno is 
found to be required for the correct orientation of these photoreceptors; and loss of nmo 
manifests itself in a change from the hexagonal to square shape of the lens (Choi and 
Benzer, 1994). nmo also has roles in cell fate specification during wing development in 
Drosophila with mutations in the gene affecting the specification of veins and the size of 
the wing (Choi and Benzer, 1994; Verheyen et al, 2001). Nemo also regulates embryonic 
development and apoptosis (Verheyen et al., 2001; Mirkovic et al., 2002) in Drosophila. 
In C. elegans, lit-1 plays a central role in the asymmetrical cell division and cell 
fate specification (Meneghini et al., 1999; Rocheleau et al., 1999). During embryogenesis 
asymmetrical divisions delineate the anterior cells from their posterior counterparts; with 
lit-1 functioning to specify posterior cell fates (Shin et al., 1999). Nlks have been shown 
to be involved in vertebrate development as well. In Xenopus xNlk is essential for neural 
development during embryogenesis. Kortenjann and colleagues (Kortenjann et al., 2001) 
demonstrate roles for mNlk in embryogenesis, neural development and haematopoiesis in 
mice. These authors showed that mice lacking mNlk die during embryogenesis; or are 
growth retarded with various neurological disorders. These mice also display aberrant 
differentiation of bone marrow stromal cells. The importance of Nlks in development has 
led to efforts to understand and characterize their activity. Emerging studies reveal roles 
for Nlks in modulating various signalling pathways; the most characterized of these 
interactions is in crosstalk with the Wnt pathway. 
Nlks and regulation of Wnt signalling 
The Wnt secretory proteins control many important developmental decisions 
including embryogenesis, specification of cell fate and polarity, body axis formation and 
neural development. The Wnt signal proceeds through at least two distinct pathways 
referred to as canonical (p-catenin-dependent) (Fig. 3)  and non-canonical (p-catenin- 
independent) pathways (Fig. 4). In the canonical pathway, Wnt signalling is mediated by 
the cytoplasmic transcriptional coactivator, p-catenin. In the absence of Wnt signal, f3 
catenin forms a complex with a group of inhibitors including Glycogen Synthase Kinase 
3P (GSK3P), the Adenomatous Polyposis Coli (APC) protein, and Axin. This interaction 
leads to phosphorylation of p-catenin and its subsequent degradation. The Wnt ligands 
bind to the Frizzled receptors, leading to the activation of the cytoplasmic protein 
Dishevelled (Dsh), which consequently inhibits GSK 3P and thereby stabilizes the 
cytoplasmic pool of p-catenin. P-catenin then translocates to the nucleus and forms a 
complex with the high-mobility-group (HMG) class of transcription factors, lymphoid 
enhancer factor 1 (Lef 1) and T-cell factor (TCF) to activate transcription of target genes. 
There is a deviation from this general scenario in C. elegans, where a Lef/TCF-like 
protein acts as a transcriptional repressor of Wnt signalling. Therefore in C. elegans, the 
p-catenin homologue WRM-1 inhibits the activity of the Lef IITCF homologue, POP-1 
to allow the transcription of target genes (reviewed in Wodarz and Nusse, 1998). 
Wnt signalling is well regulated in development to allow correct specification of 
body parts. Several studies support a role for Nlks in modulating Wnt signalling both 
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positively and negatively. In C. elegans, the Takl homologue, MOM-4 (More of MS-4) 
and the Nlk homologue LIT-1 cooperate with the Wnt signalling pathway to down- 
regulate POP-1 (Meneghini et al., 1999; Rocheleau et al., 1999). LIT-1 is activated by 
MOM-4 and forms a complex with WRM-1, this LIT-IIWRM-1 complex then moves 
into the nucleus to phosphorylate POP-1 and induce its nuclear export to allow the 
transcription of Wnt target genes (Shin et al., 1999). Recently Thorpe and Moon (2004) 
reported the finding that Nlk acts with p-catenin to de-repress Wnt target genes in 
Zebrafish, placing Nlk as a co activator of canonical Wnt signalling. 
Figure 3: The canonical Wnt pathway 
1 Cytoplasm 
pcatenin destruction 
conplex 
The Wnt ligands interact with the Fz receptors leading to the phosphorylation of Dsh. Dsh in turn inhibits 
the destruction complex made up of APC, Axin and GSK-3P; to stabilize j3-catenin in the cytoplasm. Free 
P-catenin moves into the nucleus where it interacts with the LeVTCF transcription factors to regulate the 
transcription of target genes. 
Figure 4: 
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Abbreviations: CamKII- Calmodulin-kinase II; Fmi- Flamingo; Pk- Prickle; PKC- Protein kinase C; ROK- 
Stbm-strabismus. Signalling through the non-canonical Wnt pathway is not fully understood; the figures 
presented above represent simplified versions of the two characterized lineages. (A) The PCP pathway: 
Wnt ligands interact with the Fz, and Fmi transmembrane proteins leading to the activation of Dsh; and 
subsequently Rho and ROK which influence target gene transcription in the nucleus. Another lineage 
involves the membrane proteins Stbm and Pk downstream of Fmi to regulate target genes. This latter part 
of the pathway is less understood. (B) The Ca '+-dependent pathway is activated when G proteins 
downstream of Fz activate membrane-tethered Dsh. Dsh then activates intracellular calcium ion which 
signals through one of two mediators; PKC or CamKII to influence targets. 
This is in contrast to what is seen in mammalian cells, where the TaklNlk 
pathway phosphorylates and down-regulates Lef- 1 ITcf, preventing the p-catenin-Tcf 
complex from binding to DNA and thus inhibiting transcriptional activity downstream of 
Wnt signalling (Ishitani et al., 1999; 2003). This result is supported by studies in Xenopus 
where Nlk prevents double axis formation induced by overexpression of p-catenin 
(Ishitani et al., 1999). Studies in Drosophila also indicate that nmo is an inhibitor of 
Wingless (Wg) signalling. Zeng and Verheyen (2004) showed that Nemo suppresses Wg- 
dependent gene expression in the wing disc, and affects the stability of the p-catenin 
homologue, Armadillo (Arm). Nemo is also shown to bind Arm (Bessette, Zeng and 
Verheyen, Unpublished data). However the effect of this binding is not known. 
In most instances signalling pathways employ negative feedback circuits to 
monitor their activity in a precise manner. Nlks have been demonstrated in recent studies 
to act in feedback loops to monitor Wnt signalling. Smit and colleagues (Smit et al., 
2003) showed that the Takl/NLK pathway (which inhibits Wnt signalling) is activated in 
response to Wnt signalling in vertebrates. In the Drosophila wing imaginal disc, high Wg 
signalling induces the transcription of nemo which acts to inhibit Wg (Zeng and 
Verheyen, 2004). 
In addition to the canonical pathway, new studies reveal a positive role for Nlks in 
the non-canonical Wnt pathway. The non-canonical Wnt pathway uses other mediators in 
the place of p-catenin to achieve signalling downstream of Wnt ligands and receptors. 
This pathway is divided into two separate branches, the planar cell polarity (PCP) and 
calcium ion (Ca '+)-dependent lineages. The PCP pathway controls planar tissue polarity 
in Drosophila and convergent extension (CE) movements during gastrulation in 
vertebrates. A number of proteins including the membrane protein Strabismus (Stbm), the 
LIM domain protein Prickle (Pk), the seven-pass trans-membrane cadherin Flamingo 
(Fmi), and the small guanosine triphosphate (GTPases) Rho, and Rho kinase (ROK) 
make up this pathway. Certain Wnt ligands (e.g. WntSa and Wntll) also induce the 
release of intracellular calcium which activates downstream kinases including the 
Calmodulin protein kinase I1 (CarnKII) and protein kinase C (PKC) (reviewed in Veeman 
et al., 2003). There is evidence that non-canonical Wnt signalling may antagonize the 
canonical pathway (Torres et al., 1996; Park and Moon, 2002; Topol et al., 2003; 
Veeman et al., 2003). 
The first evidence for involvement of Nlk proteins in the non-canonical Wnt 
pathway came from studies in Drosophila. Two studies by Choi and Benzer (1 994) and 
Verheyen et al., (2001) show that nmo mutants exhibit defects in PCP signalling. This 
finding is buttressed by recent evidence from vertebrates. In mammalian culture, Nlk 
functions as a downstream effector of the non-canonical Wnt ligand, Wnt-5a to inhibit P - 
catenin signalling (Ishitani et al., 2003a); while Zebrafish nlk interacts genetically with 
the non-canonical wntll homologue, silberblick (slb) to regulate gastrulation movements 
(Thorpe and Moon, 2004). 
Role of Nlk in signalling crosstalk 
Apart fiom the Wnt pathway, emerging evidence also implicates Nlks in crosstalk 
with other signalling pathways. This is through a new role of the Nlks as repressors of 
transcriptional co-activators such as the CREB binding protein (CBP/p300), thus 
repressing the transcriptional activity of several transcription factors including Nuclear 
Factor kappa B (NFkB), Smads and p53, all of which utilize CBPlp300 to activate 
transcription (Yasuda et al., 2004). As a result Nlk is likely to inhibit a wide range of 
signalling pathways that employ these transcription factors. 
Although Nlks are linked to the TGFP pathway through Takl, the potential 
involvement of these kinases in modulating TGFP signalling is not well characterized. 
Given the numerous roles Nlks play in regulating signalling in other pathways, the major 
aim of this thesis is to investigate any possible interaction between nmo and the TGFP 
pathway in Drosophila. 
TGFP signalling and wing development in Drosophila 
The wing of the fruitfly, Drosophila melanogaster presents an excellent model for 
uncovering the intricate genetic interactions that govern development in multicellular 
organisms. Drosophila possesses a pair of wings for flight that are attached to the second 
thoracic segment of the body. The adult wing consists of a wing blade in which linear 
cuticular structures known as veins are distributed in a characteristic pattern among 
groups of intervein cells. Vein cells are more compact and differentiate dark pigmented 
cuticle, hence are easily distinguished fiom intervein cells (de Celis, 2003, Milan et al., 
1997) (Fig. 5). The veins provide structural rigidity to the wing and also carry 
haemolymph, axons and in some cases trachea (transverse veins do not carry trachea) 
(reviewed in de Celis and Diaz-Benjumea, 2003). 
In Drosophila there are four longitudinal veins (L2-L5) that span the length of the 
wing, and two transverse veins (anterior crossvein, acv, and posterior crossvein, pcv) that 
connect the longitudinal veins L3 and L4, as well as L4 and L5, respectively. There are 
two incomplete longitudinal veins L1 and L6 which are located in the anterior and 
posterior compartments, respectively, of the wing. In addition, there is a marginal vein 
(M) that spans the length of the anterior wing margin (de Celis, 2003) (Fig. 5). The 
differentiation and positioning of these veins is maintained in the wildtype Drosophila 
wing through the activities of many genes. Subtle wing defects in Drosophila are readily 
identified, and many of the genes controlling wing vein patterning in the fly have been 
characterized (de Celis, 2003; Sturtevant and Bier, 1995) and have been found in most 
cases to play similar roles to direct development in other organisms. These features make 
Drosophila wing development a good model for studying genetic interactions that govern 
pattern formation during development. 
Figure 5: Structure of the adult Drosophila wing. 
Abbreviations: L1-L6- longitudinal veins; acv- anterior crossvein; pcv-posterior crossvein; M- marginal 
vein. The adult wing has longitudinal (Ll-L6) and transverse (acv and pcv) veins arranged in a species- 
specific pattern among intervein cells. The marginal vein spans the anterior wing margin, ending at the tip 
of L3. Specification of all these veins and intervein cells is controlled by specific genetic programs. Vein 
cells are densely packed and more pigmented than intervein cells. 
Vein development in the imaginal disc 
Drosophila undergoes complete metamorphosis (i.e. distinct stages with 
specialized body patterns adapting to the needs of each stage). The fertilized egg hatches 
into a mobile larva, which undergoes three successive molts (referred to as instars) to 
form an immobile pupa from which the adult fly emerges. The structures that give rise to 
the adult body are formed in the embryo and proliferate separately during larval 
development (Snodgrass, 1954; Anderson, l963a, b, l972b.: in Cohen, 1993). Epidermal 
structures of the adult head, thorax (including the wings and legs), and external genitalia 
are formed from sac-like structures called imaginal discs; while the adult abdominal 
epidermis derives from cells known as histoblast nests ( Cohen, 1993). 
Vein specification occurs in three successive stages, starting with the 3rd instar 
wing disc and involves interaction between various gene products. A number of genes 
regulated by Hedgehog (Hh), Decapentaplegic (Dpp), Notch and epidermal growth factor 
receptor (EGFR) pathways play significant roles in specifying vein and intervein regions 
in the wing. 
The precursor cells that form the wing disc are subdivided into anterior and 
posterior, as well as dorsal and ventral halves through the differential expression of the 
engrailed (en) and apterous (ap) genes respectively (Fig. 6A). en is expressed in 
posterior cells and repressed in anterior cells; while ap is expressed specifically in dorsal 
cells. These genes also influence the expression of other genes to maintain distinct 
anterior-posterior (A-P), as well as dorsal-ventral (D-V) compartments. The A-P 
boundary is set up during embryogenesis but the D-V boundary only appears in the 
second larval instar (Diaz-Benjumea and Cohen, 1993). Both en and ap activate various 
genes that contribute to growth and patterning of the disc. These subdivisions are 
maintained into the pupal stage. Vein specification is initiated in mid third instar along 
the A-P axis of the wing disc. en encodes a homeobox transcription factor and regulates 
the expression of other genes, which direct vein specification among other functions. 
Proteins encoded by the hedgehog (hh) and dpp genes play essential roles in the growth 
and specification of vein and intervein territories within the disc. 
Figure 6: Subdivisions of the 3rd instar wing imaginal disc 
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Abbreviations: A/P, antero-posterior; DN, dorso-ventral. (A)The wing disc is divided along two planes: 
anterior and posterior; dorsal and ventral. These divisions arise, and are maintained through differential 
gene expressions. Posterior cells express en, which is repressed in anterior cells. Likewise, up is expressed 
in the dorsal half, but repressed in the ventral domain. The adult wing arises from the wing blade region of 
the disc. This region folds during pupal development to bring dorsal and ventral halves in contact with each 
other. The D N  boundary becomes the future wing margin. (B) The interaction between various genes 
directs the specification of veins along the A/P boundary of the wing blade, on either surface i.e. ventral 
and dorsal. 
hh is a direct target of En and as a result is activated in the posterior compartment 
(where the en gene is expressed); however it encodes a secretory protein that diffuses to 
the anterior region to activate target genes, including the TGFP gene, dpp. Other targets 
of Hh include specific transcription factors that direct the specification of different 
longitudinal veins as well as intervein tissue. Dpp protein has long range effects and 
diffuses to reach most cells in the disc. The major mediators of Dpp signalling in the disc 
are the genes of the spalt complex, spalt (sal) and spalt-related (salr). These genes 
encode zinc finger domain transcription factors and control the positioning of provein 
territories (de Celis, 1996; de Celis et al., 2000, Milan et al., 2000). The combined effects 
of Hh and Dpp signalling therefore divides the third instar wing disc into individual 
proveins and interveins along the proximo-distal axis (mediated by specific transcription 
factors), accompanied by a general increase in the size of the disc. 
Once provein and intervein territories are specified, other factors ensure their 
integrity, width and continual maintenance of their respective fates. The EGFR and Notch 
pathways maintain vein and intervein fates respectively within the disc, and regulate each 
other's activity to maintain the position and width of the proveins. EGFR signalling is 
maintained in the centre while Notch signalling is restricted to the borders of each 
provein. In the middle of the third larval instar expression of the rhomboid (rho) gene is 
initiated in all vein primordia (Bier, 2000) probably due to Dpp activity (Yu et al, 1996). 
Rho and the EGFR ligand Star, activate the EGFR pathway in the centre of the proveins. 
As a result of EGFR signalling, the Notch ligand Delta (Dl) is expressed in the proveins. 
Dl and another ligand Serrate (Ser) are expressed in the centre, and activate Notch 
signalling at the edges of the proveins. The major function of Notch signalling is to 
maintain the width of the proveins by restricting EGFR signalling to the centre of the 
vein territory. This activity is mediated by the expression of a member of the Enhancer of 
split genes, E(spl)mb, which inhibits Rho and Star on the border of the proveins and 
prevents vein formation in these regions (de Celis et al., 1996; de Celis et al., 1997). 
Figure 7: A simplified schematic of genetic interactions guiding wing development. 
Posterior Anterior Entire imaginal disc and pupa 
Abbreviations: Dl, Delta; N, Notch; Rho, Rhomboid; Ser, Serrate; S, Star. Wing vein patterning is initiated 
from the posterior region of the wing disc, where En activates hh. Hh activates several genes (including 
dpp) that mediate vein and intervein fates. Dpp and Hh activities lead to the specification of veins among 
intervein cells. In both the imaginal disc and pupa, EGFR is activated by Rho and Star in the centre of the 
veins. EGFR in turn activates the Notch ligands Ser and Dl, which activate N in intervein cells. Notch acts 
to limit the width of the vein cells by inhibiting EGFR on the vein borders. EGFR activity is thought to be 
indirectly regulated by Dpp. 
Vein development in the pupa 
By the end of the third larval instar, the effects of Hh, Dpp, EGFR and Notch 
pathways create distinct regions where the longitudinal veins will later differentiate 
among intervein spaces. The actual differentiation of provein regions into vein cells 
occurs during pupal development, and also requires different sets of genes. For example, 
the expression of the blistered (bs) gene is maintained in the intervein cells, whereas 
expression of two POU-domain containing genes, ventral veinless (vvl) and nubbin (nb) 
are restricted to the proveins (de Celis et al., 1995; de Celis, 1998). The activities of these 
genes help maintain the subdivision of the wing blade into pro-vein and intervein 
territories during early pupal development. 
One major consequence of EGFR signalling is the activation of dpp expression in 
the provein cells where it drives the differentiation of veins (Yu et al, 1996; de Celis, 
1997). Dpp in turn contributes to maintain the expression of Dl and rho in the vein cells, 
hence reinforcing vein differentiation. 
Shortly after pupariation, the wing disc everts and folds back onto itself, allowing 
the corresponding dorsal and ventral surfaces to be in contact (Garcia-Bellido and de 
Celis, 1992). Vein and intervein territories are specified (separately) in both the ventral 
and dorsal surfaces of the wing; however during disc eversion, there are inductive signals 
from either surface that control correct vein specification on both surfaces (Milan et al, 
1997). These dorso-ventral inductive signals define the final vein differentiation pattern 
in the wing (Garcia-Bellido and de Celis, 1992). 
Unlike their longitudinal counterparts which are specified in third larval instar, 
crossveins only appear at late pupal stages (Conley et al., 2000). The acv is formed from 
components of both dorsal and ventral epithelia, while the pcv is formed entirely from the 
ventral epithelium, but depends on inductive signals arising from the dorsal epithelium 
(reviewed in Marcus, 2001). Although longitudinal vein development is well 
characterized, the development of the crossveins is not clearly understood. Genetic 
studies reveal roles for genes belonging to the crossveinless (cv) family, namely cv, cv-2, 
cv-c, cv-d, in the specification of the crossvein fate. Mutants of these genes lack one or 
both crossveins (reviewed in Diaz-Benjumea and de Celis, 2003), confirming the 
importance of these loci in crossvein development. In addition, various studies link BMPs 
as possible mediators in cross vein formation; as reductions in BMP genes have led to 
losses of the acv and pcv (Yu et al., 1996; de Celis, 1997; Haeny et al., 1998; Khalsa et 
al., 1998; Nguyen et al., 1998; Wharton et al., 1999; Ray and Wharton, 2001). The 
similarities in the effects of mutations in the cv and BMP genes support a possible 
collaboration between these genes to promote crossvein formation. In fact, the two cv 
genes that have been molecularly characterised so far (cv and cv-2) are found to encode 
proteins that may mediate BMP signalling. 
Crossveinless 2 (Cv-2) (Conley et al., 2002) and its vertebrate homologues 
(Coffinier et al., 2002; Moser, et al., 2003 Binnerts et al., 2004) contain the characteristic 
cysteine-rich (CR) domains similar to that found in the BMP antagonists, Sog and 
Chordin. The CR domains in Sog and Chordin are important for binding to the BMPs 
(Larrain et al., 2000); which suggest that Cv-2 may bind BMPs through the CR domain. 
Moser and colleagues (Moser et al., 2003) demonstrate that mammalian Cv-2 binds 
BMPs in vitro, in support of this hypothesis. Unlike the BMP antagonists however, Cv-2 
appears to have a positive effect on BMP signalling, probably through competition with 
the antagonists to bind the ligands and enhance their activity (Conley et al., 2000). This 
positive effect on BMP signalling is likely to be mediated through the presence of VWF 
domains in Cv-2, which makes it distinct from the antagonist, Sog (Conley et al,, 2000). 
Conley et a1 demonstrated the need for Cv-2 for efficient BMP signalling during the 
development of the crossveins, and proposed that it may be necessary to protect the 
ligands from cleavage by Sog, or it may be needed to activate the ligands themselves 
(Conley et al., 2000). The other gene crossveinless (cv), is found to encode a protein that 
is similar to the BMP modulator Twisted gastrulation (Tsg) (Ross et al., 2001; Vilmos et 
al., 2001). Recall that Tsg forms complexes with BMPs and their antagonists to modulate 
signalling (Oelgeschlager et al., 2000, 2003; Ross et al., 2001; Shimmi and O'Comor, 
2003). However, the exact effect of Cv on BMP signalling is not well understood. 
The importance of BMPs in crossvein development is further revealed through the 
overexpression of the BMP antagonist Sog which leads to loss of the acv and pcv (Yu et 
al., 1996). Interestingly, misexpressed Nmo also leads to a variable loss of the pcv; 
suggesting a role for nemo in crossvein development. The sensitivity of the pcv to both 
BMPs and Nemo therefore provided a perfect assay to investigate the involvement of 
nmo in TGFP signalling. Several studies from our lab indicate that nmo is involved in 
wing patterning where it probably promotes the specification of intervein fates and 
inhibits vein fates in intervein regions (Verheyen et al., 2001; Mirkovic et al., 2002). This 
role is supported by two facts: nmo mutant wings exhibit ectopic veins emerging from the 
pcv between L4 and L5 (indicative of a role for nemo in the correct formation of the pcv); 
beneath L5 and above L2. Furthermore, nmo transcript is localized in the intervein 
regions and excluded from all vein primordia in the pupal wing (Verheyen et al., 2001). 
Various gene products are strategically distributed to regulate specific fates during wing 
disc and pupal development. An example is the bs gene which is expressed in the 
intervein cells to suppress the vein fate. The localization of nmo transcript coupled with 
the mutant wing phenotypes, suggest that nmo probably acts to promote intervein fates 
during wing development. Other studies in our lab revealed that nmo exhibits genetic 
interactions between other intervein-promoting genes such as net and px; and seem to 
inhibit EGFR signalling (K. Charish, unpublished results). 
nmo's role as an intervein-determining gene places it as a possible regulator of 
BMP signalling, given that BMPs promote vein-fates. This interaction is characterized at 
various levels of the BMP pathway in this study. 
Chapter Two: Materials and Method 
Drosophila stocks and handling 
Flies were kept on standard media made of cornmeal, molasses, yeast and agar. 
The following strains were obtained from Bloomington stock centre: 
yl  w1118; P(1ac W)DadjlE4/TM3 Sbl Dpps[l l]/cyo 
gbb4 was a kind gift from Kristi Wharton. nmoadk'; and UAS-nmo c5-le are 
DB24 described in Mirkovic et al., 2002. nmo was described in D. Bessette (MSc Thesis, 
Simon Fraser University, 2003). UAS-tkv and UAS-Sog were obtained from Ethan Bier 
(University of California, San Diego). en-Gal4 was kindly provided by Norbert Perrimon 
(Harvard University). 
ptc-Gal4 is expressed along the AIP domain of the wing disc, while en-Gal4 is 
expressed in the posterior margin of the wing. Also, A9-Gal4 is expressed in the dorsal 
wing pouch of the imaginal disc, whereas 69B-Gal4 is ubiquitously expressed in the 
wing. 
Dissection and mounting of wings 
Wings were dissected from adult flies and washed in 100% ethanol, then mounted 
in Aquamount (BDH). Wings were handled at the hinge region to prevent damage. 
Aging, fixation and dissection of pupae 
White prepupae were picked from bottles and placed on a moist kimwipe in a 
petridish, and aged at 25OC for 19, 26 or 28 hours. The aged pupae were cut at the head 
and tail ends, and then fixed in 4% formaldehyde in PBS at 4 OC overnight. Pupal wings 
were dissected away from the body in Phosphate Buffered Saline (PBS) and fixed for 5 
minutes in methanol. 
Antibody Staining 
Fixed pupal wings were washed in PBS and incubated with primary antibodies at 
4•‹C overnight. The following primary antibodies were used at the concentrations 
indicated: rabbit anti-pMad, (from Tetsuya Tabata and P. ten Dijke), 1:10,000 in PBT 
(0.1% Tween 20 in PBS); and rabbit anti-P-galactosidase, (Promega), 1:5,000 in PBT. 
Wings were later washed in PBT containing 0.2% bovine serum antigen (BSA); and 
incubated with secondary antibody. Biotinylated goat-anti-rabbit (Jackson 
ImmunoResearch laboratories Inc.) was used as secondary antibody at a concentration of 
1 :200 in PBT; and detected with Streptavidin Texas Red (Jackson Immunoresearch) at a 
concentration of 1 : 1,000 in PBT, in all cases. 
In situ hybridization 
Digoxigenin (DIG)-labelled RNA probes were made using the DIG labelling kit 
(Roche) which allows the synthesis of RNA from promoter sequences by polymerase 
enzyme, using linear DNA (as a template) and ribonucleotides. The synthesis of new 
RNA strand involves the incorporation of a DIG-labelled uracil every 20-25 nucleotides. 
The synthesized RNA strand (probe) is able to pair with its complementary strand of 
RNA in tissues and is detected through staining with an antibody that specifically binds 
to DIG. Anti-sense probe is complementary to, and binds to the sense RNA; while sense 
probe does not bind to the RNA that is made from the sense strand of DNA. The sense 
probe is therefore used as a control to confirm specific localization of RNA transcript. 
cv-2 cDNA was provided by Amy Ralston (Blair lab, University of Winsconsin, 
Madison), as an insert in the pGEM vector with the promoters T7 and SP6 flanking the 
insert at the 5' and 3' ends respectively. The restriction enzymes Xho I (at the 5' end) and 
Hind I11 (at the 3' end) were used to clone the insert into the vector. Sog cDNA was 
obtained from Invitrogen Inc. in the pBluescript SK+ vector. The insert was cloned 
between T7 (at the 5' end) and T3 (at the 3' end) promoters of the pBluescript vector. The 
restriction enzymes Cla I (located at the 5' end) and Pst I (located at the 3' end) were used 
to clone the cDNA in to the vector. 
The cDNAs were linearized by digestion with specific restriction enzymes, and 
were used to generate sense or antisense probes. Linearized DNA was run on agarose gel 
to confirm the size, and later gel purified to extract the DNA. Riboprobes were generated 
through in vitro transcription. The linear DNA (from cv-2 or sog insert respectively) 
served as templates in a transcription reaction in which ribonucleotides were used to 
synthesize the probe. cv-2 cDNA was digested with Hind I11 and transcribed from the T7 
promoter, using T7 polymerase to generate a sense probe, while DNA digested with Xho 
I was used with SP6 polymerase to make antisense probe from the SP6 promoter. sog 
antisense probe was synthesized from the T3 promoter using the T3 polymerase and 
DNA digested with Pst I. On the other hand, the sense strand was made using T7 
polymerase to initiate transcription from the T7 promoter, using DNA digested with Cla I 
as template. The ribonucleotides used in these transcription reactions are contained in a 
DIG labelling mix made up of 10 mM adenosine triphosphate (ATP), 10 mM cytosine 
triphosphate (CTP), 10 mM guanosine triphosphate (GTP), 6.5 mM uridine triphosphate 
(UTP), 3.5 mM DIG-labelled UTP. Other components of the transcription reaction are 
transcription buffer (Roche): 400 mM Tris-HC1, pH 8.0; 60mM MgC12, 100 mM 
dithioerythritol (DTE), 20 mM spermidine, 100 mM NaCl, 1 p1 unitlml RNase inhibitor. 
1 pg of linear DNA was added to 2p1 1 OX DIG RNA labelling mix; 2p1 1 OX transcription 
buffer; 2p1 of appropriate RNA polymerase and sterile distilled water as needed to make 
up 20p1 final volume; in an eppendorf tube on ice. The tube was centrifuged at 13,000 
rpm briefly to mix the components and was later incubated at 37C for 2 hours. The 
transcription reaction was stopped by adding 2p1 of 0.2 M EDTA (pH 8.0). 
Fixed pupal wings were washed in PBT and digested with 0.2% proteinase K in 
PBT. The wings were then re-fixed in 4% formaldehyde in PBT at room temperature for 
25 min. In situ hybridization was performed according to Sturtevant and Bier (1 996). 
Pupal wings were incubated with probe at 55 "C overnight; and incubated with anti-DIG 
antibody (Roche, at a concentration of 1 in 2,000 in PBT) overnight at 4 "C. mRNA 
localization was detected through alkaline phosphatase reaction, using 20p1 Nitro-Blue 
Tetrazolium chloride/5-Bromo-4-Chloro-3-indolylphosphate p-Toluidine salt 
(NBTIBCIP) in lml of alkaline phosphatase buffer. Pupal wings were mounted in 80% 
glycerol and observed under the light microscope. 
Chapter Three: Results 
Genetic interaction between BMP components and nemo 
The roles of nmo and the BMPs, dpp and gbb, in wing development implicate 
nmo as a potential regulator of BMP signalling. Phenotypic analyses of the BMP genes 
confirm that they promote vein formation in the wing. Losses of either dpp (not shown) 
or gbb generally leads to loss of veins (Fig. 8F), and produce ectopic vein phenotypes 
when overexpressed (Fig. 8C, see loss of pcv). In contrast, loss of nmo produces extra 
veins in the wing (Fig. 8B), while its overexpression produces loss of veins (Fig. 8E). 
Interestingly, the phenotype induced by misexpression of Nmo resembles that of the 
misexpressed BMP antagonist Sog (Fig. 8D); and is very similar to gbb mutants (Fig. 
8F). These wing phenotypes support a possible role for nmo in TGFP signalling, and like 
sog, it probably functions to inhibit the pathway. 
The possible interaction between these genes was tested through genetic studies, 
using nemo and components of the BMP pathway. As described above, the BMP proteins 
Dpp and Gbb signal through the Type I receptor Tkv; and overexpression of Tkv leads to 
increased activation of the BMP pathway (de Celis, 1997). Thus, the BMP pathway was 
activated ectopically through the overexpression of the Tkv protein, using the UAS- Gal4 
system (Brand and Perrmimon, 1993). In this system, the Gal4 gene is inserted in front of 
a genomic enhancer that drives Gal4 expression in specific tissues. Gal4 binding sites 
(Upstream activating sequences, UAS) are inserted within the promoter region of the 
gene to be misexpressed, allowing this gene of interest to be activated in those cells in 
which Gal4 is produced, when flies bearing these two separate lines are crossed together. 
Figure 8: nmo and BMPs exhibit opposing phenotypes. 
wildtype 
Loss of hnction nmo mutants exhibit ectopic veins (significantly) between L4 and L5 (B, arrow); and are 
similar to wings overexpressing the BMP gene, gbb (C, arrow). Ectopically expressed nmo leads to loss of 
the pcv (E, arrowhead) and resembles wings ectopically expressing the BMP antagonist Sog (D). A similar 
phenotype is also seen in the gbb loss of function mutant (F, arrowhead); demonstrating opposing roles of 
nmo and BMPs in crossvein development. 
The patched (ptc) gene is expressed along the AIP boundary of the wing disc; 
along the same domain that Dpp is expressed, so theptc-Gal4 epidermal driver was used 
to overexpress tkv in the wing. ptc Gal4>UAS-tkv flies develop wings that are slightly 
smaller than wildtype, and also show a fusion of veins L3 and L4 (Fig. 9C). In contrast 
wings from flies overexpressing nmo under the ptc-Gal4 driver do not show any severe 
phenotype (Fig. 9B). Overexpression of these two genes in the same fly resulted in a 
dramatic rescue of the UAS-tkv phenotype, with almost complete separation of veins L3 
and L4 (Fig. 9D). In a separate study, A. Zeng (Verheyen Lab) found that expressing a 
constituvely active Tkv receptor results in flies with bifurcated wings, and this phenotype 
is rescued by the expression of UAS-nmo (A. Zeng, unpublished results). Our lab also has 
found a similar effect of nmo on the BMP cytoplasmic mediator, Mad. Overexpression 
of UAS-mad produced wings that are broader than wildtype and show defects in vein 
patterning; again this phenotype is suppressed by ectopically expressing nmo in the same 
background (Zeng A., 2004, unpublished data). 
Figure 9: Nmo antagonizes BMP signalling 
wildtype 
Overexpression of nmo under the ptc-Gal4 driver produces a phenotype (B) that is similar to wildtype (A). 
However, ptc-Gal4>UAS-tkv results in the fusion of the veins L3 and L4 (C); but these veins are separated 
to almost wildtype positions by ptc-Gal4> UAS nmoCS~" (D) .  
The above results strongly support a possible antagonistic interaction between 
nrno and BMPs. This fact was pursued fbrther by examining possible genetic interaction 
between nrno and the Dpp antagonist dad. Tsuneizumi and colleagues (Tsuneizumi et al., 
1997) demonstrated that Dad specifically inhibits Dpp signalling; so in a bid to clarify 
nmo's role in the pathway, mutational analysis was carried out between nrno and dad. A 
P element insertion into the dad gene (used to monitor dad transcription) produces no 
visible wing phenotype (Fig. lOB), however dad-lacZ,nmo double mutants produce 
wings with ectopic vein phenotypes more severe than is seen in nrno mutants alone (Fig. 
10C and D). This may indicate a synergistic relationship between dad and nmo, and 
further supports the view that nrno may be exerting an inhibitory effect on the BMP 
pathway. 
Nemo's effect on BMP signalling 
The Smadl homologue, Mad is a central component of BMP signalling in 
Drosophila, and is phosphorylated by activated Tkv in response to ligand stimulation. 
Phosphorylation of Mad is therefore often used as a measure of BMP signalling 
(Tanimoto et al., 2000), and an antibody that is directed against the phosphorylated Mad 
(pMad) protein is employed to detect signalling levels. BMP signalling is very crucial for 
vein development and is needed in the pupal wings for the correct formation of the veins 
(de Celis, 2003). I carried out pMad staining in pupal wings either mutant for nrno or 
overexpressing nrno to determine whether nmo has any effect on the signalling level of 
the BMP ligands. As can be seen in Fig. 11 pMad staining is present along all the veins 
but is missing from intervein territories in the wildtype wing (Fig. 1 lA), supporting the 
need for BMP signalling in vein specification. 
Figure 10: loss of dad enhances nrno ectopic vein phenotype 
wildtype 
dad-lacZ wings ( B )  do not show any obvious phenotype and look like wildtype (A). However, these wings 
display ectopic vein phenotypes when combined with nmoadk' in the same background; and are more severe 
than the nrno phenotype alone (compare arrows in D and C). 
This staining pattern is also observed in the overexpressed nrno background (Fig. 11E); 
however nrno mutant pupal wings show ectopic pMad staining in the extra veins (Fig. 
11B and F). In addition to BMP signalling, other pathways such as the EGFR pathway 
promote vein formation during the pupal stage so high pMad levels may be the result of 
an indirect effect of nrno on one of these pathways. BMP signalling however is found to 
be required for the specification of the crossveins between 18-20 hours after puparium 
formation (apf) (Conley et al., 2000). Most of the extra veins in nrno mutant wings are 
around the region of the posterior crossvein, raising the possibility that they are of the 
same fate as the pcv. The pMad staining was therefore repeated at 19 hours apf to 
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confirm that the results observed earlier are due to changes in BMP signalling levels. 
Interestingly, the same ectopic staining was observed at 19 hours apf (Fig. 11E). This 
experiment was performed on the more severe dad-lacZ,nmo double mutant pupal wings 
and high pMad levels were observed in the extra veins (Fig. 11C). This increases the 
possibility that Nemo is targeting the BMP pathway and the high pMad levels in nmo 
wings is due to the loss of the inhibitory activity of Nemo on the pathway. nmo's effect 
on BMP signalling was also observed in the wing imaginal disc by A. Zeng (Verheyen 
Lab), who noticed comparatively high pMad levels in clones of cells in the imaginal disc 
that lose nmo activity (unpublished results). Together these results suggest that Nemo 
negatively regulates BMP signalling and its loss may lead to high levels of signalling 
from these ligands. 
Figure 11: pMad is elevated in nmo ectopic veins 
Anti-pMad staining of 26 hr old (A-C), and 19 hr old @-F) pupal wings. pMad is present along the veins, 
with no detectable difference in the levels in wildtype and ecto ically expressed 69B-Ga14>UAS nmoc5-'" 
(mmpare D to E). However mutant n m  wings; mod' and nmogBz4 (B and F respectively); as well as dad- 
l a c ~ n r n o ~ '  (C) wing show pMad staining in ectopic veins (arrows in B; C, and F). 
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Although the genetic interaction and pMad levels reveal that nmo may have 
antagonistic effects on BMP signalling this effect will be irrelevant without any influence 
on target gene expression. The significance of Nemo's activity on BMP signalling was 
examined by monitoring the transcription levels of the Dpp target gene, dad. Recall that 
dad is expressed in response to Dpp signalling but acts in a negative feedback loop to 
suppress Dpp activity (Tsuneizumi et al., 1997). One way of measuring transcriptional 
activity of Drosophila genes is through enhancer trap insertion of the E. coli lacZ gene 
under the control of the enhancer of a target gene. The lac2 gene activity is detected by 
staining for the P-galactosidase protein (a product of l a d )  levels to determine the 
transcriptional activity of the target gene (O'Kane and Gehring, 1987). This technique 
0824 was used to determine the transcription of dad in dad-lac~,nmo"~~'/nmo pupal wings, 
through anti - p-galactosidase staining of pupal wings. dad is expressed in the intervein 
regions and appears to be elevated on the borders of the veins in dad-lac2 pupal wings 
(Fig. 12A and C) probably to regulate the activity of Dpp and limit it to the veins. In the 
nmo background expression is slightly elevated around the ectopic veins (Fig. 12 B and 
D); indicating that nmo may be required to suppress Dpp signalling in these regions. This 
effect was also seen in imaginal wing discs, where dad expression is suppressed by 
ectopic nmo (A. Zeng, 2004, unpublished results). 
Effect of Nemo on BMP pathway components 
Since the evidence seen so far strongly indicates that nmo is having a negative 
impact on TGFP signalling; it is important to identify the exact way it is interacting with 
the pathway as well as how it is exerting its effect on the pathway. In an effort to 
characterize the interaction, I looked at the effects of Nemo on other components of the 
BMP pathway. 
Figure 12: nmo inhibits ectopic dad transcription 
Anti-j3-galactosidase staining of 19 hr (C, D); and 26 hr pupal wings. Expression is localized in the 
intervein cells and is enriched along the vein borders (probably to inhibit Dpp-induced ectopic vein 
formation); but is excluded from the vein cells in dad-lacZ. Ectopic veins in nmo mutants however show 
dad expression (arrows in B and D); indicating that nmo is affecting BMP target gene expression in regions 
that correspond to ectopic veins. 
As discussed above, Sog has been reported to inhibit the BMP pathway probably 
through binding to, and cleaving the ligands. Evidence for the inhibitory action of Sog in 
this pathway in wing development is demonstrated through the opposite phenotype 
induced by the overexpressed protein compared to the mutant phenotype of the BMP 
genes (compare Fig. 8D to F) which is characterized by loss of vein tissue in the 
crossveins. In support of this view, Yu and colleagues reported that Sog is a Dpp 
antagonist and inhibits Dpp activity in intervein tissues (Yu et al., 1996). I explored the 
possibility of sog and nmo acting through a similar pathway to inhibit BMP signalling. 
This was done by misexpressing Sog in a nmo background. Overexpression of sog under 
the en-Gal4 driver leads to the loss of both crossveins (Fig. 13B). As discussed above, 
BMPs play significant roles in crossvein specification and their loss leads to the absence 
of these veins (Fig. 8F) (de Celis, 1997; Haerry et al., 1998; Khalsa et al., 1998; Nguyen 
et al., 1998; Wharton et al., 1999; Ray and Wharton, 2001), therefore the loss of 
crossvein phenotype displayed by flies overexpressing Sog indicates that Sog might be 
interfering with BMP-mediated development of the crossveins (Yu et al., 1996; Conley et 
al., 2000). The specific loss of the crossveins could be due to the fact that the crossveins 
are formed in tissues that are originally specified as intervein early in wing development 
(Conley et al., 2000), the same tissues where sog normally expressed (Yu et al., 1996). 
As discussed above, the crossveins appear late in pupal development at a stage when 
longitudinal veins and intervein tissues are already specified, so the crossveins are 
formed within designated intervein tissue (Conley et al., 2000). Recall that loss of nmo 
leads to the formation of ectopic veins some of which are located near the pcv (Fig. 13C). 
The overexpression of sog in this nmo mutant background led to the rescue of nmo 
ectopic vein phenotype; however the UAS-sog phenotype (i.e. loss of both crossveins) is 
unchanged (Fig. 13D). This interaction is complicated by the presence of ectopic veins 
between L2 and L3 (Fig. 13D, arrows) which are difficult to explain. 
Figure 13: nrno shows a complex interaction with sog. 
nrno ectopic veins (arrows in C) are rescued through misexpression of sog in the posterior compartment of 
the wing; however there is no change in the phenotype caused by ectopic expression of sog; i.e. loss of the 
crossveins (arrowheads B and D). The interaction is complicated by the presence of ectopic veins between 
L3 and L4 (arrow in D). 
Although this result does not confirm any interaction between sog and nmo, it 
consolidates nmo's antagonistic role on the BMP pathway, since the ectopic veins 
induced by loss of nrno in the posterior region of the wing are rescued by overexpressing 
sog (Fig. 13D). The high levels of Sog may thus be preventing the formation of ectopic 
veins (a role that nrno is likely to perform in wildtype wings) in the absence of nrno 
function. If this assumption is true, then nrno may also be acting in a parallel pathway to 
sog but they both ultimately inhibit BMP activity. 
There is no conclusive evidence that nrno interacts with sog from the experiment 
above, hence the investigation of interaction between nrno and the BMP components was 
extended to the cv genes. As noted above, these genes are critical to the formation of the 
crossveins, and their mutants exhibit similarities to mutations in the BMP genes. One 
would suspect a possible collaboration between BMPs and Cv proteins in crossvein 
specification, as proposed by Conley et al., (2000), who showed that Cv-2 may be 
required to potentiate BMP signalling in the crossvein. The first effort then was to 
determine if the BMPs interact with the cv genes. I therefore generated double mutants 
between dpp and the cv genes, cv-2 and cv-c to examine genetic interactions between 
them. These double mutants display only the dpp phenotype (Fig. 14E and F), suggesting 
a genetic interaction, and also placing BMPs downstream of these cv genes. This is not 
surprising, in light of the proposed role of the Cv-2 protein for instance, in activating 
BMP ligands (Conley et al., 2000). It is possible then that the other crossveinless genes 
may perform similar roles in modulating BMP signalling in the crossvein. 
With the evidence of this possible interaction, I then proceeded to find out 
whether nmo interacts with these genes. This was done by generating double mutants 
between nmo and each of the cv genes, cv, cv-2, cv-c, and cv-d. Mutants for the cv genes 
produce wings that lack the pcv (cv-2', cv-cl, and cv-dl; Fig. 15 C, D and E) or both the 
acv and pcv (cvl, Fig. 158). The nmo mutant alleles used nmoDB2'and nmoadkl both show 
0824 
ectopic veins near the pcv (Fig. 15 A and F respectively) and the nmo allele also 
show ectopic veins beneath L5 (Fig. 15A). Double mutants generally displayed an 
additive phenotype which is characterized by the cv loss of crossveins, and nmo ectopic 
veins (Fig. 15G, I, and J), except in the case of cv-2; nmo mutants where the nmo ectopic 
vein phenotype is lost completely; although the wings retain the round shape of nmo 
mutant wings (Fig. 15 H). This finding demonstrates that cv-2 suppresses the nmo ectopic 
vein phenotype; and it is possible that these two genes interact at some level. 
Figure 14: cv genes show genetic interaction with dpp. 
wildtype cv-2' 
Loss of dpp leads to truncations of the tip of veins L4 and L5 (D, arrows) and loss of the cv genes cv-2 and 
cv-c results in loss of the pcv (arrowheads in B and C respectively). Double mutants of both dpp and either 
of the cv genes resulted in the display of the dpp phenotype (compare arrows in E and F to D). 
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Any possible effect of nrno on the BMP pathway through 0 - 2  is likely to be 
intracellular, since Nlk is shown to be localised in the cytoplasm or the nucleus (Brott et 
al., 1997); and the structure of Cv-2 suggests it is secretory and mainly extracellular 
(Conley et al., 2000). Since nrno and vertebrate n l h  are found to influence the effect of 
transcription factors (e.g. LefITcf and CBPlp300) as reviewed above; a possible means of 
interaction might be at the level of transcription of the 0 - 2  gene. I therefore monitored 
the effect of nrno on the transcription of the cv-2 through in situ hybridization, a method 
that allows transcript levels to be detected within tissues. 
Using this method, cv-2 transcript levels were monitored in overexpressed Nemo 
and nmo mutant backgrounds in 28 hour pupal wings. Previous studies show that cv-2 
expression is highest at 28 hours apf (Conley et al., 2000). cv-2 transcript is located 
mainly in the two pcv in wildtype wings (Fig. 16A), and my results agree with published 
results (Conley et al., 2000). I used the 69B-Gal4 epidermal driver to ectopically express 
nrno in the wing; and did not observe any clear difference in the cv-2 transcript levels in 
the pupal wings of this genotype compared to wildtype (Fig. 16B). In this genotype the 
pcv is generally reduced or absent so this result is not surprising. However, in nmo 
mutant pupal wings cv-2 transcript is present in high amounts in the ectopic veins (Fig. 
16C) suggesting that Nemo may be required under wildtype conditions to inhibit cv-2 
transcription in the regions corresponding to extra veins. This will explain the similar 
levels of expression in wildtype and ectopically expressed nrno wings since any transcript 
in these cases is limited to the regular crossveins. 
Although the in situ hybridization supports the assumption that nrno may be 
repressing cv-2 transcription; it does not link it directly to this activity. 
Figure 16: nmo regulates 0-2 transcription 
cv-2 in situ hybridization of 28 hr old pupal wings. The cv-2 transcript is localized in the crossveins and 
appears to be unchanged in wildtype and misexpressed 6 9 ~ - ~ a l 4 > ~ ~ ~ - n m o " ~ - ' "  (arrowheads in A and B 
respectively). It is however very high in nmoDBZ4 ectopic veins (arrows in C). Expression is slightly reduced 
in wings losing one copy of cv-2 (D), but there is no noticeable change in expression in the nmo mutant 
background, whether the wings have one Q or both (F) copies of cv-2 (arrows in E and F). 
I attempted to see whether reduced levels of cv-2 activity will result in a 
corresponding reduction of transcript levels in nmo mutant background. The cv-2' allele 
is a hypomorph and shows reduced transcript levels as a heterozygote compared to 
wildtype levels (Conley et al., 2000). Surprisingly, there was no difference in cv-2 
message levels in either heterozygous or homozygous cv-2 in nmo mutant backgrounds 
(Fig. 16E or F). I conclude that loss of nmo may override any changes in cv-2 
transcription in the heterozygous wing, thus leading to the high cv-2 transcript levels. 
Also since the ectopic veins are present in these wings, cv-2 transcription is likely to go 
up; whether it is present in wildtype or heterozygous amounts. 
One common feature of most genes that promote intervein fate (including nmo) is 
that their mutants exhibit ectopic veins in the wing. Since the high transcript levels are 
located within these extra veins in nmo wings, it is possible that all genes that promote 
the intervein fate may control cv-2 transcription in a manner similar to nmo. If this is true 
then one will assume that other intervein-determining genes will likely have a similar 
effect on cv-2 transcription. I monitored the expression in mutants of another gene, net, 
that like nmo promotes intervein fates, and shows ectopic veins in similar regions of the 
wing as nmo (compare Fig. 17B and C). Consistently, cv-2 expression is detected within 
the extra veins in net mutants (Fig. 17F, arrowheads), and more importantly appear to be 
of similar level compared to nmo mutants (compare Fig. 17E to F). 
The above results indicate that cv-2 levels must be well regulated to ensure 
correct vein specification; and support roles for nmo and other intervein-promoting genes 
in this regulation. Given the fact that cv-2 is implicated in BMP signalling, nmo's effect 
on the pathway may be at the level of cv-2 transcription. 
There is also a possibility of nmo positively controlling the transcription of the 
sog gene as a means of inhibiting the pathway, so I used in situ hybridization to follow 
the expression of sog at 19 and 26 hours apf in the pupal wings. However there is no 
change in the level of sog expression in wildtype , ectopic, or mutant nmo wings (Fig. 
18A-E). 
Figure 17: nmo and nei produce similar effects on cv-2 transcription 
wildtype nrnoDBz4 net' 
net' 
A-C shows adult wings and D-F are 28 hour pupal wings showing cv-2 transcript localization. cv-2 in situ 
hybridization in net1 pupal wings exhibit similar high expression in ectopic veins (F arrowheads), as seen in 
nmo (E). 
Figure 18: nmo shows no effect on sog transcription. 
wildtype nrnouu24 
sog in situ hybridization in wildtype (A and D); nmoDB24; and 6 9 ~ - ~ a l 4 > ~ ~ ~ - n m o ' ~ - ' "  pupal wings, at 26 
hr apf (A-C), and 19 hr apf @ and E). sog expression levels appear to be unchanged in all cases. 
Chapter Four: Discussion 
nmo in vein development 
The studies presented above support a regulatory role for Nemo on TGFO 
signalling during wing development in Drosophila. The phenotypes of nmo mutants 
alone suggest the need for this gene in maintaining correct fates in the wing (Verheyen et 
al., 2001; Mirkovic et al., 2002). Additionally, nmo is expressed in the intervein regions 
(Verheyen et al., 2001) in pupal wings and may be regulating intervein differentiation. 
The ectopic vein phenotypes in nmo mutant wings coupled with the localization of the 
transcript in pupal wings gives strong credence to a role in preventing vein formation. 
Nemo antagonizes the BMP pathway 
As discussed above the specification of vein or intervein fates in the Drosophila 
wing is directed by distinct sets of genes which interact to allow correct distribution of 
these structures in the wing. Generally intervein-determining genes (such as bs and net) 
act to promote intervein fates by suppressing vein-determining genes (such as EGFR) in 
regions that differentiate into intervein cells. Both dpp and gbb promote the formation of 
veins, while nmo likely promotes intervein fates. It is possible that nmo may interact with 
the BMP genes to suppress their effects in intervein regions. The interaction between nmo 
and tkv (the Type I BMP receptor) (Fig. 9) support the assumption that nmo may be an 
antagonist of TGFP signalling. Further evidence supporting this line of thought is the 
similar results (as in the case of tkv and nmo) obtained using another positive modulator 
of TGFO signalling, Mad (Zeng A, unpublished results) which produced a phenotype that 
is rescued by nrno when both are overexpressed. Also the severity of ectopic veins seen in 
nrno mutants in combination with dad- lad  further argues for a possible inhibitory role of 
nrno on this pathway. Since dad was shown to antagonize Dpp signalling (Tsuneizumi et 
al., 1997), it is possible that both dad and nrno are needed to effectively inhibit the 
activities of Dpp in vein development. Perhaps the strongest evidence that implicates nmo 
as a negative regulator is the high levels of ectopic pMad in nmo mutant pupal wings. As 
discussed above, pMad levels represent one of the ways through which BMP signalling 
activity is measured. Interestingly, pMad levels remain localized mainly within the 
regular veins but are present in the ectopic veins in nrno mutants, clearly demonstrating a 
role for nmo in suppressing BMP signalling, probably at regions where the ectopic veins 
differentiate in nmo mutants. 
As explained above, vein formation is well regulated to maintain the species- 
specific pattern in Drosophila melanogaster. Several genes identified as promoting 
intervein fates have been shown to repress the activities of vein-promoting genes outside 
the vein-competent domains. A well characterized example is the bs gene which is 
expressed in the intervein regions and inhibits vein formation at the third instar and the 
pupal stages. Also net is shown to inhibit the expression of rho in intervein cells 
(Brentrup et al., 2000). Recall that rho is expressed in the vein cells where it mediates 
EGFR signalling at both larval and pupal stages. Another example is the restriction of 
EGFR signalling to larval and pupal provein cells by Notch. BMPs play prominent roles 
to promote vein fate in the wing; hence they need to be controlled to allow correct vein 
patterning. Nemo may be one of several inhibitory genes that may suppress BMP 
signalling in certain regions of the wing to ensure correct vein specification. The results 
presented in this study support such an antagonistic role for Nmo on BMP signalling. 
However the exact mechanism(s) through which this regulation might be occurring is not 
known and a number of possibilities are discussed below. 
Regulation of signalling 
Tkv 
As reviewed earlier, the Type I receptor is subject to regulation to prevent ligand- 
independent signalling. This regulation could be used as a means of suppressing ligand- 
induced signalling by regulators. Nemo may therefore be acting on the cytoplasmic 
region of Tkv to lock it in a non-functional state which could explain the rescue of the 
UAS-tkv phenotype by UAS-nmo. On the other hand, nmo may interact with, and inhibit 
other components of the pathway to produce the same effect on Tkv as observed. 
dad 
Dad has been shown to specifically antagonize Dpp signalling (Tsuneizumi et al., 
1997); if nmo also acts to inhibit BMP signalling, then the effect of losing both nmo and 
dad might be enough to permit uncontrolled TGFP signalling resulting in the more severe 
ectopic wing vein phenotype (Fig. 9D). However, it is possible that Dad interacts with 
Nemo physically, implying they both need each other's activity to fully exert their effects 
on TGFP signalling. Such a co-operation between I-Smads and other proteins has been 
seen by others. For example, Yasuda et a1 demonstrated that Tob protein is able to 
repress BMP signalling in Xenopus through its interaction with I-Smads (Yasuda et al., 
2003). Smurfs also induce nuclear export of I-Smads and have been shown to mediate 
their inhibitory activity on TGFP signalling in vertebrates (Ebisawa et al., 2001). There is 
no evidence so far which identified an activator for Dad, and Nemo could be a potential 
candidate. This interaction between Dad and Nemo if true, may be necessary to activate 
Dad's binding to the receptor or Mad. It may also allow Dad to be recognized by Dsmurf, 
which will induce its nuclear export. We are currently doing biochemical studies to 
determine whether nmo and dad might be interacting physically and the relevance of this 
possible interaction on Dad's inhibitory role in TGFP signalling. 
Mad 
Mad presents yet another potential source of crosstalk between the BMP pathway 
and Nemo. R-Smads are targeted by several proteins to regulate TGFI) signalling. These 
Smads contain MAPK phosphorylation sites (PXSP sequence) in their linker region (Itoh 
et al., 2000; Massague, 1998) (Fig. 2). MAPK phosphorylation of Smads at these sites 
prevents the nuclear accumulation of Smad complexes (Kretzschmar et al., 1997a, 1999) 
and is believed to be a means of regulating TGFI) signalling (Massague, 1998). In 
vertebrate cells, the MAPK Erk under the influence of Ras phosphorylates the R-Smads 
on their linker domain, and prevents their ligand-induced nuclear import, resulting in 
impaired TGFD signalling. It is also believed that other kinases can equally target these 
Erk phosphorylation sites in Smads (reviewed in Derynck and Zhang, 2003). In view of 
this, it may be true that Nemo phosphorylates Mad in these regions to impair BMP 
signalling. This is quite interesting, as analysis between mouse Nlk and Erk reveal some 
similarity between these proteins (Brott, 1998). Additionally, A. Zeng (Verheyen lab) 
recently found that Nemo binds Mad in cell culture, raising the possibility of Nemo 
acting through Mad to affect TGFP signalling. It is possible that Nemo phosphorylates 
Mad at MAPK sites in its linker region; preventing it from translocating to the nucleus 
and thus inhibiting BMP target genes. As discussed earlier, Smurfs target Smads for 
proteosome mediated-degradation; and recognize Smads through a PY motif in the linker 
region (Fig. 2). It is possible that Nemo may be required to phosphorylate Mad to allow 
DSmurf to recognize and degrade it. One may also argue that the binding of Nemo to 
Mad is likely to prevent the phosphorylation of Mad by the receptors. Any of these, if 
true might explain the elevated pMad levels in the absence of functional Nemo. 
Transcriptional regulation of mediators 
In theory, it is possible that Nemo inhibits transcriptional activity of the Smads on 
target genes as a means of suppressing signalling; especially since Nlk plays a similar 
role in regulating Wnt signalling in vertebrates (Ishitani et al., 1999). As mentioned 
earlier, Nlk is found to inhibit the transcriptional activity of Smads indirectly by 
repressing the Smad transcriptional coactivator, CBPlp300 (Yasuda et al., 2003). The 
level of ectopic pMad staining seen in the absence of Nemo activity however suggests 
that Nemo might be functioning upstream, or at the level of Mad; or may influence the 
transcription of mediators or regulators of TGFP signalling. 
Sog has been shown to inhibit BMP signalling, especially in wing development 
(Yu et al., 1996). The complexity of the genetic interaction between nmo and sog as well 
as nmo's lack of influence on sog transcription probably rules out sog as a possible 
mediator of nmo's effect on the BMP pathway. Further genetic studies using loss of 
function alleles of sog may be important in making this assumption. 
The Cv-2 protein has been linked with the BMP pathway as a positive modulator 
(Conley et al., 2000); and the results presented here (Fig. 14E) support the view that cv-2 
is acting upstream of BMPs and may be essential to their function. This leaves Cv-2 in 
an important position in the BMP pathway, and its levels may be essential in regulating 
the pathway. Nemo's effect on cv-2 transcription raises the possibility that it may be 
interacting with the BMP pathway through its regulation of cv-2 transcription. It is likely 
that nmo downregulates cv-2 transcription in the interveins; and its absence is what 
causes elevated transcription of cv-2 as seen in the ectopic veins (refer to Fig. 16C). 
Double mutants of nmo and cv-2 show more of the cv-2 phenotype (Fig. 15H) implying 
that cv-2 may be downstream of Nemo function; probably at the level of transcriptional 
regulation. It is striking that both cv-2 expression and pMad levels are elevated in the 
nmo ectopic veins. One may conclude then that lack of the inhibitory effect of Nemo on 
cv-2 message may lead to hyperactivation of the BMP pathway (accounting for the high 
pMad levels) in regions that correspond to the extra veins. It may also be true that Nemo 
is affecting both events simultaneously to effectively control signalling. 
A drawback to the assumption above is that cv-2 transcription is equally affected 
by another intervein-determining gene; net (Fig. 17F). However, BMP-induced activity 
may be controlled through the suppression of cv-2 transcription in the intervein region by 
certain genes that promote intervein fate, including net and nmo. This perception could be 
true, given that the cv-2 transcript is localized specifically in the crossveins, and appear 
only in the ectopic veins in both net and nmo mutants. This specific localization will 
imply that the ectopic veins seen in these mutants are of the crossvein fate. Insect wings 
are thought to have arisen from ancestors with many veins that have undergone 
progressive loss of veins through evolution (de Celis and Diaz-Benjumea, 2003). It is 
suggested that crossveins might have arisen as a result of fusion between some 
longitudinal veins during evolution (Garcia-Bellido and de Celis, 1992; de Celis and 
Diaz-Benjumea, 2003). Probably Drosophila have evolved certain genes (including cv-2) 
to maintain the crossveins; and others (including net and nrno) to prevent reversal to the 
ancestral state (i.e. appearance of ectopic veins) through the repression of cv-2 
transcription. Cv-2 may in turn function through the BMP pathway (among others) to 
promote the crossvein fate as demonstrated already (Conley et al., 2000) and in this 
study. Therefore net and nmo may both inhibit BMP signalling by virtue of repressing cv- 
2 transcription. There is no evidence that net functions to inhibit BMP signalling; 
probably pMad staining of net mutants could be useful in testing this possibility. 
The TGFP pathway is controlled by various regulators to ensure correct signal 
levels in the cell. Nmo and its homologues are emerging as regulators of signalling 
pathways to mediate correct development in various organisms. Results from this study 
suggest potential involvement of nmo in regulating TGFP signalling in the Drosophila 
wing. The initial evidence that connected nmo to the TGFP pathway is through Takl, but 
studies so far indicate that dTakl might not be playing any role in wing development 
(Mihaly et a1 2001; Vidal et al., 2001). nmo's effect on wing development may therefore 
be independent of Takl. Recently two additional tak-like genes have been identified in 
Drosophila, so their characterization will be useful to determine whether the taWnmo 
pathway contributes to wing vein patterning. 
In this study however nrno appears to function as an inhibitor of the TGFP 
pathway in wing development. This activity is presumably essential to prevent BMP- 
induced ectopic vein formation in the wing. Further studies will be important to address 
the question of how nrno specifically interacts with the pathway. This regulatory role of 
nmo may be of high significance in addressing developmental conditions that may be due 
to excessive TGFP signalling. It will be interesting to see if this possible interaction 
occurs in other organisms, including vertebrates. 
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